Overactivation of the MAPK signaling pathway leads to the production of IL-8 and VEGF by tumor cells, promoting tumor angiogenesis, growth, and metastasis and inhibiting T lymphocyte infiltration into tumor tissue and resistance to immune checkpoint therapy [134,135]. Here, CXCL8 is linked to neoplasm.